Insight

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller/X

Oct 8, 2024, 15:49

Manel Esteller: Epigenetic Hallmarks in Cancer in Cancer Discovery

Manel Esteller, Director of the Josep Carreras Leukaemia Research Institute, shared a post on X:

“Epigenetic Hallmarks in Cancer in Cancer Discovery, AACR Promoter CpG island hypermethylation-associated silencing targets all classical and new dimension hallmarks of cancer by Weinberg MIT, Whitehead Institute and Hanahan, Ludwig Cancer, EPFL.”

Manel Esteller

The Epigenetic Hallmarks of Cancer

Source: Manel Esteller, Mark A. Dawson, Cigall Kadoch, Feyruz V. Rassool, Peter A. Jones, Stephen B. Baylin

Manel Esteller

AACR cancer Cancer Discovery Cigall Kadoch EPFL Feyruz V. Rassool Hanahan Josep Carreras Leukaemia Research Institute Ludwig Cancer Manel Esteller Mark A. Dawson OncoDaily Oncology Peter A. Jones Stephen B. Baylin Weinberg MIT Whitehead Institute

Invest in Health Policy: A Conversation with Professor Andreas Charalambous

FDA Approves Cosibelimab-ipdl for Treatment of Metastatic or Locally Advanced Cutaneous Squamous Cell Carcinoma

Dolph Lundgren’s Fight for Life: How He Survived Kidney Cancer After 9 Years of Battle

Agenus and Tanner Pharma Partner to Expand Global Access to BOT/BAL

Bispecific Antibody M701 Offers a Novel Treatment Option for Malignant Ascites

Special Coverage